1:11:12

Intensification, not complication

4:13

Inside Charles River's Client-Centric Approach: Interview with Ahmad Hussin, CVP Global CDMO

7:50

Innovating Pharma with GELITA: Leadership in Gelatin & Collagen Peptides

25:42

Video Interview: Claus Zieler of Astellas and EFPIA

5:47

Navigating Market Changes: Piramal Pharma's Growth and Key Industry Trends

4:58

Just – Evotec Biologics Expands in Europe

7:31

Redefining Sterile Manufacturing Standards with Kindeva

21:42

The Cell Preservation Society

18:15

Debra Weiss from the Bill & Melinda Gates Medical Research Institute Talks About her Career

22:42

Interview: Courtney Silverthorn from the Foundation for the National Institute’s of Health

0:22

The new dawn for gene-edited medicines brings both optimism and caution #shorts

0:33

May the fourth industrial revolution be with you… #shorts

0:49

April Issue of The Medicine Maker

21:06

Interview with Cardinal Health’s Fran Gregory on the High Cost of Pharmaceutical Drugs / Part 2

18:46

Interview with Cardinal Health’s Fran Gregory on the High Cost of Pharmaceutical Drugs / Part 1

15:40

Interviewing Christian Baber, Chief Portfolio Officer, The Pistoia Alliance

0:47

How a study involving Super Mario Odyssey and depression captured imaginations.

0:35

Remembering Rosalind Franklin: DNA Therapeutics Pioneer

0:42

Artificial Intelligence in Medicine and Drug Discovery: Hyper or High Performance?

0:36

Pfizer on Young Talent and Internships

0:49

January / February Issue of the Medicine Maker

0:35

A guiding light for CRISPR (interviewing Paul Donohoue from Caribou Biosciences)

0:38

The FDA Modernization Act opens the door for more innovative alternatives to animal testing

11:41

In Conversation With Joel Eichmann, Green Elephant (Advanced Therapies Week - Phacilitate 2024)

12:57

In Conversation With George Eastwood (Advanced Therapies Week- Phacilitate 2024)

10:39

In Conversation With Stella Vnook, Likarda (Advanced TherapiesWeek - Phacilitate 2024)

8:38

In Conversation With Delara Motlagh, Catalent (Advanced Therapies Week - Phacilitate 2024)

0:34

Company of the Year Awards - Vote Now!

6:59

In Conversation with Mike Riley, CEO of Veranova

5:02

Vetter, a leading CDMO, on its evolving role and plans for the future

1:23

Looking Back on Some of the TOP FDA Approvals from 2023

1:28

The Medicine Maker Spelling Bee - Test your pharmaceutical drug name knowledge now!

17:29

Ali Pashazadeh from Treehill Partners offers his advice for keeping on track for commercial success.

0:49

November / December issue of The Medicine Maker

7:00

An interview with Stevanato Group and how its integrated solutions benefit pharma customers.

7:12

Discovery to Clinical Supply; How Biosynth’s latest Acquisition Addresses Peptide Customer Needs

10:03

In Conversation with Nick Armstrong, Senior Director of Digital Enablement at CAI

1:00

The World’s First CRISPR-Based Therapeutic Approval #shorts #CRISPR

0:49

October Issue of The Medicine Maker

0:49

August Issue of The Medicine Maker

2:28

A Timeline of Drug Development for Alzheimer’s Disease

0:49

June Issue of the Medicine Maker

16:10

In Conversation With Josh Ludwig, Global Commercial Director, ScaleReady at ISCT 2023 Paris Meeting

13:13

In Conversation With Phil Vanek, CTO at Gamma Biosciences at the ISCT 2023 Paris Annual Meeting

13:08

In Conversation With Angela Osborne, CEO at eXmoor Pharma at the ISCT 2023 Paris Annual Meeting

15:08

In Conversation With Vered Caplan, CEO at Orgenesis at the ISCT2023 Paris Annual Meeting

0:49

April Issue of The Medicine Maker

10:20

Advanced Therapies Week - Phacilitate. Ivan Wall, Head of the Advanced Centre for Advanced Therapies

5:22

Advanced Therapies Week - Phacilitate. Natalie Elizalde, Chief Business Development, VIVEBiotech

8:52

Advanced Therapies Week - Phacilitate. Stuart Gibb Head of Scientific Strategy CGT, Terumo

10:51

Advanced Therapies Week - Phacilitate. Vered Caplan, CEO Orgenesis

9:18

Advanced Therapies Week - Phacilitate. Matthew Lakelin, co-founder, Trakcel

8:52

Advanced Therapies Week - Phacilitate. Kim Barnes, Executive Vice President, Phacilitate

12:54

In Conversation with Christophe le Ret of Umicore PMC at CPhI 2022

4:40

In Conversation with Gian Connor of Corning at CPhI 2022

8:40

In Conversation with Niek Stapel of Veranova at CPhI 2022

10:32

Fluid Management: The Oft-Overlooked Path to Reduced Risk and Increased Efficiency with Erik Storm

21:04

Interviewing Keith Horspool at Excipient World 2022

5:55

Interviewing David Gough from the Association for Accessible Medicines at Excipient World 2022

3:51

Thermo Fisher Scientific: 60 Years of Gibco Innovation

15:39

An Interview with Vishal Salvi - Pharma: AI Uptake and Cybersecurity Considerations

27:19

Redefining Multiple Myeloma

1:01

The Medicine Maker Evaluating Pfizer's Revenues Post-Pandemic

47:19

How Can The Pharma Industry Improve Clinical Trials?

2:18

From Quality Control to Cold Chain: What the Pandemic Taught Us - Datwyler animated article

58:48

A Question of Sustainability: How Can Pharma Companies Up Their Environmental Game?

15:40

Paulo Fontoura, the Global Head and SVP of Neuroscience and Rare Diseases Development at Roche

1:07:06

Setting the Course for Novel Excipients: Featuring Experts from IPEC-Americas

11:03

In Conversation with Nick Shackley of Johnson Matthey - CPhI 2021

8:15

In Conversation with Peter Soelkner of Vetter Pharma - CPhI 2021

12:28

Joe Healey of NanoSyrinx: Interview on Cell and Gene Therapy Part 2

14:41

Joe Healey of NanoSyrinx: Interview on Cell and Gene Therapy Part 1

4:37

Sharon Brownlow from the Cell & Gene Therapy Catapult on the top trends in cell therapy: Part 2

8:51

Sharon Brownlow from the Cell & Gene Therapy Catapult on the top trends in cell therapy: Part 1

8:53

Tamas Masztis from Kite discusses his career and the top trends in cell therapy: Part 2

7:21

Tamas Masztis from Kite discusses his career and the top trends in cell therapy: Part 1

39:01

Mike Rea, CEO at IDEA Pharma, talks about pharma positioning and launch strategies

26:19

The Medicine Maker Sitting Down With G-CON’s Maik Jornitz

21:23

Discussing Cell Therapy Manufacturing with Edwin Stone

7:46

Why Characterization is Key: Bio-Rad's Mark White Talks CGT

7:03

Synthesizing Innovation: With Christophe Le Ret, Umicore PMC

1:18

Polpharma Biologics - Why work in Utrecht

1:18

Why work at Polpharma Biologics

1:30

Polpharma Biologics - Utrecht Site Introduction

1:35

Polpharma Biologics - Biosimilar Novel Pipeline

1:30

Polpharma Biologics - Gdansk Site Introduction

1:22

Polpharma Biologics - Warsaw Site Introduction

1:05

Polpharma Biologics - Quality

1:14

Polpharma Biologics - Cell Line Development

1:22

Polpharma Biologics - Discovery & Optimization

1:10

Polpharma Biologics - Microbial Capabilities

2:53

Polpharma Biologics - Brand Launch Video

59:47

Facing the COVID-19 Crisis: Leadership and the Future of Pharma

6:55

The Future of Pharma Manufacturing: With Shawn Walker, Johnson Matthey

46:48

Pandemic Preparedness and Learning from the Past Roundtable

7:33

The Patient-First Perspective: With Dominique Henry, Terumo

1:51

Lonza's GS piggyBac Animated

3:31

Balancing Cell Therapy: With Nolan Paulson, Juno Therapeutics, at Thermo Fisher Scientific’s vertX

3:16

The Known Unknowns: With Andy Spasoff, AstraZeneca | MedImmune, at Thermo Fisher Scientific’s vertX

2:59

Matthew's Journey: We talk with Matthew Moon, CAR T Recipient, at Thermo Fisher Scientific’s vertX